Ryman Healthcare (RYM) Stock Price, Fundamentals & Analysis
Price
1.57 AUD
-1.26%
Last trade: Sep 25, 2026, 02:01 PM GMT+10
Updated: Sep 27, 2026, 07:47 PM GMT+10
Price history
Over the past year RYM traded between 1.54 AUD and 2.61 AUD, closing at 1.57 AUD on Sep 25, 2026.
Key statistics
| Market cap | 1.59B AUD |
|---|---|
| EPS (TTM) | -0.33 NZD |
| Dividend yield | 0% |
| Annual dividend | 0 AUD |
| Payout ratio | 0% |
| 52-week range | 1.54 – 2.64 |
| 52-week change | -34.9% |
| Beta | 0.34 |
| Price / book | 0.48 |
| Revenue (TTM) | 854.47M NZD |
| Revenue growth (YoY) | 11.9% |
| Gross margin | 9.5% |
| Operating margin | 5.3% |
| Profit margin | -20.1% |
| Return on equity | -4.1% |
| Debt / equity | 39.2 |
| Volume | 918 |
| Average volume | 3,649 |
| Next earnings | Nov 26, 2026 |
| Exchange | ASX |
Profile
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Christchurch, New Zealand
- Website
- rymanhealthcare.co.nz
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia. The company's villages provide apartments and townhouses, and assisted-living in serviced apartments, and care center, which offers rest homes, hospitals, specialist dementia care, and respite care services. Ryman Healthcare Limited was founded in 1984 and is based in Christchurch, New Zealand.
Overview
What RYM does
Ryman Healthcare (RYM) develops, owns, and operates integrated retirement villages, rest homes, and hospitals for older people in New Zealand and Australia. Its villages provide apartments and townhouses, assisted-living in serviced apartments, and care centres that offer rest homes, hospitals, specialist dementia care, and respite care services. Founded in 1984 and headquartered in Christchurch, New Zealand, Ryman Healthcare operates in the Healthcare sector, specifically the Medical Care Facilities industry. On the ASX, it is part of the broader Australian healthcare landscape alongside peers such as Ramsay Health Care (RHC), CSL (CSL), and Sigma Healthcare (SIG).
Key numbers explained
- Price: The current share price is 1.57 AUD. This is the last traded price and the starting point for any valuation.
- Price-to-book (P/B): At 0.48, the stock trades below its book value, which can suggest the market values the company's assets less than their accounting worth, or it may reflect other factors.
- Dividend yield: The dividend yield is 0%, and 0% of earnings are paid out as dividends, meaning the company currently does not distribute cash to shareholders.
- Beta: A beta of 0.34 indicates the share tends to move less than the overall market, often interpreted as lower volatility.
- Market capitalisation: The marketCap is 1.59B AUD, representing the total market value of all outstanding shares.
- Revenue growth: Trailing 12-month revenue is 854.47M NZD, growing 11.9% year over year.
- Profit margin: The profitMargin is -20.1%, meaning the company is currently operating at a loss on a net basis.
- 52-week range: The lowest and highest price in the last 52 weeks was 1.54 – 2.64, with the current price near the low end of that range.
What to watch
Ryman Healthcare operates in a sector sensitive to government policy on aged care funding and regulation in both New Zealand and Australia. Changes in healthcare spending, occupancy rates in retirement villages, and labour costs for care staff can all affect results. The company's next earnings release is scheduled for Nov 26, 2026, which is a key date for updated financials. For broader context, investors often compare healthcare facility operators with other ASX-listed names; for example, 4DMedical (4DX) and Telix Pharmaceuticals (TLX) operate in different healthcare sub-sectors. RYM is also listed on the ASX 200, which tracks the 200 largest companies by market capitalisation on the Australian Securities Exchange.
Latest news & filings
No recent headlines.
Frequently asked questions
Does RYM pay a dividend?
No. The dividend yield is 0%, and 0% of earnings are paid out as dividends.
What is the RYM P/E ratio?
The facts do not provide a P/E ratio. The trailing 12-month earnings per share is -0.33 NZD, which means the P/E ratio cannot be meaningfully calculated from a negative earnings figure.
Where can I buy RYM?
RYM trades on the ASX under the symbol RYM. You can buy it through any broker that provides access to the Australian Securities Exchange.
What does Ryman Healthcare do?
Ryman Healthcare develops, owns, and operates integrated retirement villages, rest homes, and hospitals for older people in New Zealand and Australia.
What is the market cap of RYM?
The market capitalisation is 1.59B AUD.
Related
More on RYM
Track RYM in your portfolio
Hold RYM at XTB, IBKR, Tradeville, Revolut or Trading 212? InvestPane brings every broker into one dashboard — allocation, performance and dividends in one place.
Start free